These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 8605000)

  • 1. Antibodies against the N-terminus of IL-8 receptor A inhibit neutrophil chemotaxis.
    Quan JM; Martin TR; Rosenberg GB; Foster DC; Whitmore T; Goodman RB
    Biochem Biophys Res Commun; 1996 Feb; 219(2):405-11. PubMed ID: 8605000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-8 induces neutrophil chemotaxis predominantly via type I IL-8 receptors.
    Hammond ME; Lapointe GR; Feucht PH; Hilt S; Gallegos CA; Gordon CA; Giedlin MA; Mullenbach G; Tekamp-Olson P
    J Immunol; 1995 Aug; 155(3):1428-33. PubMed ID: 7636208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor.
    Chuntharapai A; Kim KJ
    J Immunol; 1995 Sep; 155(5):2587-94. PubMed ID: 7650389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergy between proinflammatory ligands of G protein-coupled receptors in neutrophil activation and migration.
    Gouwy M; Struyf S; Catusse J; Proost P; Van Damme J
    J Leukoc Biol; 2004 Jul; 76(1):185-94. PubMed ID: 15075362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderate inhibitory effect of interleukin-10 on human neutrophil and monocyte chemotaxis in vitro.
    Vicioso MA; Garaud JJ; Réglier-Poupet H; Lebeaut A; Gougerot-Pocidalo MA; Chollet-Martin S
    Eur Cytokine Netw; 1998 Sep; 9(3):247-53. PubMed ID: 9831173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoattractant receptors for interleukin-8 and C5a: expression on peripheral blood leukocytes and differential regulation on HL-60 and AML-193 cells by vitamin D3 and all-trans retinoic acid.
    Zahn S; Zwirner J; Spengler HP; Götze O
    Eur J Immunol; 1997 Apr; 27(4):935-40. PubMed ID: 9130647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential cross-regulation of the human chemokine receptors CXCR1 and CXCR2. Evidence for time-dependent signal generation.
    Richardson RM; Pridgen BC; Haribabu B; Ali H; Snyderman R
    J Biol Chem; 1998 Sep; 273(37):23830-6. PubMed ID: 9726994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoattractant receptor cross talk as a regulatory mechanism in leukocyte adhesion and migration.
    Campbell JJ; Foxman EF; Butcher EC
    Eur J Immunol; 1997 Oct; 27(10):2571-8. PubMed ID: 9368612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrasting responses to multiple chemotactic stimuli in transendothelial migration: heterologous desensitization in neutrophils and augmentation of migration in eosinophils.
    Kitayama J; Carr MW; Roth SJ; Buccola J; Springer TA
    J Immunol; 1997 Mar; 158(5):2340-9. PubMed ID: 9036983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that a receptor-operated event on the neutrophil mediates neutrophil accumulation in vivo. Pretreatment of 111In-neutrophils with pertussis toxin in vitro inhibits their accumulation in vivo.
    Nourshargh S; Williams TJ
    J Immunol; 1990 Oct; 145(8):2633-8. PubMed ID: 1976700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophils regulate their own apoptosis via preservation of CXC receptors.
    Dunican A; Grutkoski P; Leuenroth S; Ayala A; Simms HH
    J Surg Res; 2000 May; 90(1):32-8. PubMed ID: 10781372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoattractant cross-desensitization of the human neutrophil IL-8 receptor involves receptor internalization and differential receptor subtype regulation.
    Sabroe I; Williams TJ; Hébert CA; Collins PD
    J Immunol; 1997 Feb; 158(3):1361-9. PubMed ID: 9013980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of monocyte chemoattractant protein-1 and interleukin-8 receptors on subsets of T cells: correlation with transendothelial chemotactic potential.
    Qin S; LaRosa G; Campbell JJ; Smith-Heath H; Kassam N; Shi X; Zeng L; Buthcher EC; Mackay CR
    Eur J Immunol; 1996 Mar; 26(3):640-7. PubMed ID: 8605932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hamycin inhibits IL-8-induced biologic response by modulating its receptor in human polymorphonuclear neutrophils.
    Manna SK; Samanta S; Samanta AK
    J Immunol; 1997 Nov; 159(10):5042-52. PubMed ID: 9366432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selected antibodies to leukocyte common antigen (CD45) inhibit human neutrophil chemotaxis.
    Harvath L; Balke JA; Christiansen NP; Russell AA; Skubitz KM
    J Immunol; 1991 Feb; 146(3):949-57. PubMed ID: 1671052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unidirectional heterologous receptor desensitization between both the fMLP and C5a receptor and the IL-8 receptor.
    Blackwood RA; Hartiala KT; Kwoh EE; Transue AT; Brower RC
    J Leukoc Biol; 1996 Jul; 60(1):88-93. PubMed ID: 8699129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-desensitization of chemoattractant receptors occurs at multiple levels. Evidence for a role for inhibition of phospholipase C activity.
    Richardson RM; Ali H; Tomhave ED; Haribabu B; Snyderman R
    J Biol Chem; 1995 Nov; 270(46):27829-33. PubMed ID: 7499254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-8 and NAP-2 differ in their capacities to bind and chemoattract 293 cells transfected with either IL-8 receptor type A or type B.
    Ben-Baruch A; Bengali K; Tani K; Xu L; Oppenheim JJ; Wang JM
    Cytokine; 1997 Jan; 9(1):37-45. PubMed ID: 9067094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T lymphocyte recruitment by interleukin-8 (IL-8). IL-8-induced degranulation of neutrophils releases potent chemoattractants for human T lymphocytes both in vitro and in vivo.
    Taub DD; Anver M; Oppenheim JJ; Longo DL; Murphy WJ
    J Clin Invest; 1996 Apr; 97(8):1931-41. PubMed ID: 8621778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A His19 to Ala mutant of melanoma growth-stimulating activity is a partial antagonist of the CXCR2 receptor.
    Baly DL; Horuk R; Yansura DG; Simmons LC; Fairbrother WJ; Kotts C; Wirth CM; Gillece-Castro BL; Toy K; Hesselgesser J; Allison DE
    J Immunol; 1998 Nov; 161(9):4944-9. PubMed ID: 9794430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.